This study is designed to compare the use of special prism glasses to placebo treatment for children with symptomatic convergence insufficiency.
The Base-in for Convergence Insufficiency Treatment Trial (BI-CITT) is a multi-center, placebo-controlled, masked, clinical trial designed to compare the benefits of base-in prism for patients with convergence insufficiency (CI). The goals of this clinical trial are: * To compare the effectiveness of Base-in prism and Placebo eyeglasses for the treatment of CI in children * To study the long-term effect of these treatments for CI * To identify factors that may be associated with successful treatment of CI with base-in prism
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
72
University of Alabama, Birmingham, College of Optometry
Birmingham, Alabama, United States
Southern California College of Optometry
Fullerton, California, United States
NOVA College of Optometry
Fort Lauderdale, Florida, United States
Symptom score on the Convergence Insufficiency Symptom Survey
Near point of convergence
Positive fusional vergence at near
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bascom Palmer Eye Institute
Miami, Florida, United States
Indiana University College of Optometry
Bloomington, Indiana, United States
State University of New York, College of Optometry
New York, New York, United States
The Ohio State University, Optometry Coordinating Center
Columbus, Ohio, United States
The Ohio State University
Columbus, Ohio, United States
Eye Institute, Pennsylvania College of Optometry
Philadelphia, Pennsylvania, United States
University of Houston, College of Optometry
Houston, Texas, United States